CORE--Molecular Resources Core
CORE--分子资源核心
基本信息
- 批准号:7312504
- 负责人:
- 金额:$ 27.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-03-01 至 2010-02-28
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Core C, the Molecular Resources Core, will provide molecular reagents and services to all four projects and will be crucial to the completion of the specific aims of each proposal in the Program Project. The proposal for a Molecular Resources Core is a continuation of the original Core C. The overall function of Core C is to provide molecular reagents and expertise, including generation of deletion and site-directed mutants and incorporation into the desired expression vectors, creation of minigene constructs, generation of adenoviral and retroviral constructs for transduction of primary endothelial cells and designing and generating appropriate siRNA based constructs. This core will be directed by Dr. Randal A. Skidgel and will be staffed by a full-time Senior Research Specialist (Dr. Barbara Keith), full- time Research Specialist (TBN) and part-time Research Associate (Vidas Dumasias). Consolidating these efforts in Core C will result in increased speed and efficiency in accomplishing the research tasks outlined in each of the
projects and uniformity of approaches and methods so that resutts from each project can be compared. In addition, it will allow strict quality control and consistency of molecular reagents to be used by the various projects. Furthermore, an added and important benefit of the centralized Core C will be to markedly decrease expenses compared to a scenario in which each project would generate its own molecular resources. Regular meetings of the Core leader with the Senior Research Specialist and project leaders will assure coordination and prioritization of the generation of molecular reagents and assure that the desired reagents are provided in a timely manner to the component projects.
核心C,即分子资源核心,将为所有四个项目提供分子试剂和服务,并将对完成计划项目中每个提案的具体目标至关重要。分子资源核心的提议是对原有核心C的延续。核心C的总体功能是提供分子试剂和专业知识,包括产生缺失和定点突变并整合到所需的表达载体中,创建微基因构建体,生成腺病毒和逆转录病毒构建体用于转导原代内皮细胞,以及设计和产生适当的基于siRNA的构建体。该核心将由兰德尔·A·斯基德格尔博士领导,并将配备一名全职高级研究专家(Barbara Keith博士)、全职研究专家(TBN)和兼职研究助理(Vidas Dumasias)。将这些努力整合到核心C中将导致在完成每个
项目以及途径和方法的一致性,以便可以比较每个项目的结果。此外,它还将允许严格的质量控制和各种项目使用的分子试剂的一致性。此外,与每个项目将产生自己的分子资源的方案相比,集中式核心C的一个额外且重要的好处将是显著降低费用。核心领导与高级研究专家和项目领导的定期会议将确保分子试剂生成的协调和优先次序,并确保及时向组成部分项目提供所需的试剂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Randal A Skidgel其他文献
Randal A Skidgel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Randal A Skidgel', 18)}}的其他基金
Developing a new drug for treating myocardial ischemia/reperfusion injury
开发治疗心肌缺血/再灌注损伤的新药
- 批准号:
10491205 - 财政年份:2021
- 资助金额:
$ 27.47万 - 项目类别:
Developing a new drug for treating myocardial ischemia/reperfusion injury
开发治疗心肌缺血/再灌注损伤的新药
- 批准号:
10325868 - 财政年份:2021
- 资助金额:
$ 27.47万 - 项目类别:
Targeting integrin outside-in signaling for treating sepsis
靶向整合素由外向内信号传导治疗脓毒症
- 批准号:
10461718 - 财政年份:2018
- 资助金额:
$ 27.47万 - 项目类别:
Targeting integrin outside-in signaling for treating sepsis
靶向整合素由外向内信号传导治疗脓毒症
- 批准号:
10625353 - 财政年份:2018
- 资助金额:
$ 27.47万 - 项目类别:
Post-translational Regulation of High Output NO and Endothelial Barrier Dysfuncti
高输出 NO 和内皮屏障功能障碍的翻译后调节
- 批准号:
8059128 - 财政年份:2011
- 资助金额:
$ 27.47万 - 项目类别:
Post-Translational Regulation of High Output NO and Endothelial Barrier Dysfuncti
高输出 NO 和内皮屏障功能障碍的翻译后调节
- 批准号:
7367821 - 财政年份:2007
- 资助金额:
$ 27.47万 - 项目类别:
Post-Translational Regulation of High Output NO and Endothelial Barrier Dysfuncti
高输出 NO 和内皮屏障功能障碍的翻译后调节
- 批准号:
7312500 - 财政年份:2006
- 资助金额:
$ 27.47万 - 项目类别:
Post-Translational Regulation of High Output NO and Endothelial Barrier Dysfuncti
高输出 NO 和内皮屏障功能障碍的翻译后调节
- 批准号:
6967980 - 财政年份:2005
- 资助金额:
$ 27.47万 - 项目类别:














{{item.name}}会员




